Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/30385
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sever, Nurettin İlter | - |
dc.contributor.author | Cengiz Şahin, Sevilay | - |
dc.date.accessioned | 2020-06-08T12:12:54Z | |
dc.date.available | 2020-06-08T12:12:54Z | |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1479-6694 | - |
dc.identifier.uri | https://hdl.handle.net/11499/30385 | - |
dc.identifier.uri | https://doi.org/10.2217/fon-2018-0332 | - |
dc.description.abstract | S6K2, the newer member of S6 Kinase family, is a crucial modulator of Akt/mTOR signaling pathway and is a member of AGC kinase family that regulates cellular growth and survival. S6K1 and S6K2 share high sequence similarity; therefore, S6K2 had been underestimated. However, recent studies displayed distinct functions of S6K2. Activated by both Akt/mTOR and Ras/Raf/Mek/Erk signaling pathways, S6K2 regulates cancer cell survival via different routes. Complexation with antiapoptotic proteins BRAF and PKC? avoids non-small-cell lung cancer cells from apoptosis upon FGF-2 stimulation. Indirect upregulation of the translation of antiapoptotic proteins Bcl-XL and XIAP in HEK293T cells and interference with TNF-induced apoptosis in MCF-7 cells are other routes of cancer cell survival. The aforementioned studies on S6K2 necessitate the development of therapies targeting only on S6K2. Studies targeting S6K2 may help to build important roads for cancer therapy. © 2018 Future Medicine Ltd. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Future Medicine Ltd. | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | cancer cell survival | en_US |
dc.subject | cancer therapy | en_US |
dc.subject | S6 kinase 2 | en_US |
dc.subject | B Raf kinase | en_US |
dc.subject | fibroblast growth factor 2 | en_US |
dc.subject | initiation factor 4E binding protein 1 | en_US |
dc.subject | mammalian target of rapamycin | en_US |
dc.subject | mitogen activated protein kinase | en_US |
dc.subject | pf 4708671 | en_US |
dc.subject | protein bcl xl | en_US |
dc.subject | protein kinase B | en_US |
dc.subject | protein kinase inhibitor | en_US |
dc.subject | Raf protein | en_US |
dc.subject | Ras protein | en_US |
dc.subject | S6 kinase | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | X linked inhibitor of apoptosis | en_US |
dc.subject | ribosomal protein S6 kinase, 70kD, polypeptide 2 | en_US |
dc.subject | Akt/mTOR signaling | en_US |
dc.subject | apoptosis | en_US |
dc.subject | breast cancer | en_US |
dc.subject | cancer cell | en_US |
dc.subject | cancer prognosis | en_US |
dc.subject | cell growth | en_US |
dc.subject | cell proliferation | en_US |
dc.subject | cell survival | en_US |
dc.subject | complex formation | en_US |
dc.subject | correlation analysis | en_US |
dc.subject | drug targeting | en_US |
dc.subject | enzyme activation | en_US |
dc.subject | enzyme structure | en_US |
dc.subject | HEK293 cell line | en_US |
dc.subject | human | en_US |
dc.subject | malignant neoplasm | en_US |
dc.subject | MCF-7 cell line | en_US |
dc.subject | non small cell lung cancer | en_US |
dc.subject | priority journal | en_US |
dc.subject | protein expression | en_US |
dc.subject | protein family | en_US |
dc.subject | protein function | en_US |
dc.subject | protein localization | en_US |
dc.subject | Review | en_US |
dc.subject | sequence homology | en_US |
dc.subject | signal transduction | en_US |
dc.subject | upregulation | en_US |
dc.subject | chemistry | en_US |
dc.subject | enzymology | en_US |
dc.subject | metabolism | en_US |
dc.subject | molecularly targeted therapy | en_US |
dc.subject | neoplasm | en_US |
dc.subject | pathology | en_US |
dc.subject | procedures | en_US |
dc.subject | Cell Proliferation | en_US |
dc.subject | Humans | en_US |
dc.subject | Molecular Targeted Therapy | en_US |
dc.subject | Neoplasms | en_US |
dc.subject | Ribosomal Protein S6 Kinases, 70-kDa | en_US |
dc.title | S6K2 promises an important therapeutic potential for cancer | en_US |
dc.type | Review | en_US |
dc.identifier.volume | 15 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 3306 | |
dc.identifier.startpage | 3306 | en_US |
dc.identifier.endpage | 3316 | en_US |
dc.authorid | 0000-0002-9320-4146 | - |
dc.authorid | 0000-0003-3361-4319 | - |
dc.identifier.doi | 10.2217/fon-2018-0332 | - |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.pmid | 30730779 | en_US |
dc.identifier.scopus | 2-s2.0-85058448121 | en_US |
dc.identifier.wos | WOS:000453874200010 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale University | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Review | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | 17.05. Molecular Biology and Genetics | - |
crisitem.author.dept | 17.05. Molecular Biology and Genetics | - |
Appears in Collections: | Fen-Edebiyat Fakültesi Koleksiyonu PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
4
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
5
checked on Nov 21, 2024
Page view(s)
36
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.